| Literature DB >> 29225920 |
Anna Karin Hedström1, Torbjörn Åkerstedt2,3, Lars Klareskog4, Lars Alfredsson1.
Abstract
BACKGROUND: Environmental factors play a prominent role in rheumatoid arthritis (RA) aetiology. Shift work has previously been associated with increased RA risk in females. The aim of this study was to investigate the potential association, including a dose-response association, between permanent night shift work, rotating shift work and day-oriented shift work and risk of developing anticitrullinated peptide antibodies (ACPA)-positive and ACPA-negative RA.Entities:
Keywords: circadian rhythm; melatonin; rheumatoid arthritis; shift work; sleep restriction
Year: 2017 PMID: 29225920 PMCID: PMC5706490 DOI: 10.1136/rmdopen-2017-000475
Source DB: PubMed Journal: RMD Open ISSN: 2056-5933
Characteristics of cases and controls among those who have and have not been exposed to shift work before the index year
| ACPA-positive cases | ACPA-negative cases | Controls | ||||||||||
| Kind of shift work | Never | Permanent night shift work | Day-oriented shift work | Rotating shift work | Never | Permanent night shift work | Day-oriented shift work | Rotating shift work | Never | Permanent night shift work | Day-oriented shift work | Rotating shift work |
| Total (n) | 828 | 97 | 144 | 163 | 514 | 54 | 67 | 84 | 1537 | 192 | 244 | 252 |
| Swedish (n, %) | 724 (87) | 83 (86) | 119 (83) | 141 (87) | 466 (91) | 47 (87) | 58 (87) | 68 (81) | 1387 (90) | 165 (86) | 211 (86) | 209 (83) |
| University degree (n, %) | 170 (21) | 27 (28) | 35 (24) | 30 (18) | 114 (22) | 20 (37) | 14 (21) | 10 (12) | 434 (28) | 58 (30) | 68 (28) | 54 (21) |
| Smoking (n, %) | 592 (72) | 72 (74) | 115 (80) | 121 (74) | 308 (60) | 25 (46) | 56 (84) | 57 (68) | 914 (59) | 124 (65) | 174 (71) | 165 (65) |
| Alcohol (g/week, SD) | 32.6 (50.8) | 42.7 (58.8) | 36.7 (52.8) | 28.3 (45.3) | 40.0 (60.5) | 33.1 (50.1) | 46.7 (78.1) | 31.7 (39.0) | 50.1 (67.7) | 45.9 (53.9) | 59.0 (75.0) | 50.5 (85.3) |
| Body mass index (mean, SD) | 21.5 (2.8) | 21.5 (3.2) | 21.7 (2.9) | 22.0 (4.0) | 21.6 (2.8) | 21.4 (3.1) | 22.1 (3.0) | 22.1 (3.1) | 21.3 (2.7) | 21.5 (3.0) | 21.7 (2.9) | 21.2 (2.8) |
ACPA, anticitrullinated peptide antibodies.
ORs with 95% CIs of developing rheumatoid arthritis (RA) for subjects who have been exposed to permanent night shift work, rotating shift work, or day oriented shift work, compared with those who have never been exposed
| ACPA-positive | RA | ACPA-negative RA | ||||
| Type of shift work | ca/co* (n, %) | OR (95% CI)† | p Value | ca/co* (n, %) | OR (95% CI)† | p Value |
| Never | 828 (67)/1537 (69) | 1.0 (reference) | 514 (71)/1537 (69) | 1.0 (reference) | ||
| Day oriented shift work | 144 (12)/244 (11) | 1.3 (1.0 to 1.7) | 0.04 | 67 (9)/244 (11) | 1.0 (0.7 to 1.4) | 0.9 |
| Rotating shift work | 163 (13)/252 (11) | 1.3 (1.0 to 1.6) | 0.03 | 84 (12)/252 (11) | 1.1 (0.9 to 1.5) | 0.4 |
| Permanent night shift work | 97 (8)/192 (9) | 0.7 (0.6 to 0.9) | 0.005 | 54 (8)/192 (9) | 0.8 (0.6 to 1.0) | 0.03 |
*Exposed cases and controls
†Adjusted for age, gender, residential area, ancestry, and smoking.
ACPA, anticitrullinated peptide antibodies.
ORs with 95% CI of developing rheumatoid arthritis (RA) for subjects who reported past exposure to permanent night shift work compared with those who had never been exposed, by duration (years) and intensity (nights/months) of night shift work
| ACPA-positive RA | ACPA-negative RA | |||||
| Duration | ca/co* | OR (95% CI)† | p Value | ca/co* | OR (95% CI)† | p Value |
| 0 | 828/1537 | 1.0 (reference) | 514/1537 | 1.0 (reference) | ||
| <5 years | 149/275 | 0.8 (0.6 to 1.0) | 0.06 | 81/275 | 0.9 (0.7 to 1.2) | 0.5 |
| 5–10 years | 45/89 | 0.7 (5.1 to 1.1) | 0.1 | 24/89 | 0.8 (0.5 to 1.3) | 0.4 |
| >10 years | 65/152 | 0.6 (0.4 to 0.9) | 0.005 | 35/152 | 0.7 (0.4 to 1.0) | 0.06 |
| p for trend | 0.002 | 0.04 | ||||
| Intensity | ca/co* | OR (95% CI)† | p | ca/co* | OR (95% CI)† | p |
| 0 | 828/1537 | 1.0 (reference) | 514/1537 | 1.0 (reference) | ||
|
| 184/362 | 0.8 (0.6 to 1.0) | 0.02 | 97/362 | 0.8 (0.6 to 1.1) | 0.1 |
| >10 nights/months | 75/154 | 0.7 (0.5 to 1.0) | 0.03 | 43/154 | 0.8 (0.6 to 1.2) | 0.4 |
| p for trend | 0.007 | 0.2 | ||||
*Number of exposed cases and controls.
†Adjusted for age, gender, residential area, ancestry, smoking, educational level and shift work.
ACPA, anticitrullinated peptide antibodies.